Cargando…
Inhibition of colorectal cancer liver metastasis in BALB/c mice following intratumoral injection of oncolytic herpes simplex virus type 2 for the induction of specific antitumor immunity
Liver metastasis represents the most prominent metastasis of colorectal cancer (CRC) and is the leading cause of CRC mortality, making the early prevention of this event very important. While current CRC therapies include surgery, radiotherapy and chemotherapy, no effective treatment option for CRC...
Autores principales: | Zhang, Wen, Wang, Feifei, Hu, Xiao, Liang, Jing, Liu, Binlei, Guan, Qi, Liu, Shangmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313052/ https://www.ncbi.nlm.nih.gov/pubmed/30655834 http://dx.doi.org/10.3892/ol.2018.9720 |
Ejemplares similares
-
A Novel Oncolytic Herpes Simplex Virus Type 2 Has Potent Anti-Tumor Activity
por: Zhao, Qian, et al.
Publicado: (2014) -
Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
por: Yin, Jie, et al.
Publicado: (2017) -
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial
por: Zhang, Bo, et al.
Publicado: (2021) -
Stability and anti-tumor effect of oncolytic herpes simplex virus type 2
por: Wang, Yang, et al.
Publicado: (2018) -
Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
por: Yin, Lei, et al.
Publicado: (2017)